Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cytochrome P450 family 11 subfamily B member 1 | 0.563 | 0.615 | 8.2E-07 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 1991 | 2019 | ||||||||
|
SRY-box transcription factor 5 | 0.545 | 0.769 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
LEM domain containing 3 | 0.582 | 0.731 | 1.00 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2012 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
phenotype | 0.340 | None | 1.000 | 1 | 0 | 2009 | 2017 | ||||||||
|
forkhead box G1 | 0.522 | 0.692 | 0.94 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
forkhead box G1 | 0.522 | 0.692 | 0.94 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
SIN3 transcription regulator family member A | 0.551 | 0.692 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
ankyrin repeat domain 11 | 0.556 | 0.808 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
cytochrome P450 family 17 subfamily A member 1 | 0.462 | 0.769 | 2.6E-04 |
|
disease | 0.310 | strong | 1.000 | 0 | 0 | 1991 | 1991 | ||||||||
|
hydroxysteroid 17-beta dehydrogenase 3 | 0.641 | 0.346 | 8.5E-07 |
|
disease | 0.790 | strong | 1.000 | 7 | 17 | 1994 | 2018 | ||||||||
|
retinoic acid induced 1 | 0.545 | 0.731 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 12 | 0 | 2004 | 2010 | ||||||||
|
dihydropyrimidine dehydrogenase | 0.493 | 0.846 | 3.4E-22 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2011 | 2011 | ||||||||
|
nuclear factor I A | 0.599 | 0.808 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
heterogeneous nuclear ribonucleoprotein U | 0.575 | 0.654 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
NAD kinase 2, mitochondrial | 0.691 | 0.346 | 6.5E-02 |
|
disease | 0.600 | moderate | 1.000 | 5 | 0 | 2012 | 2018 | ||||||||
|
2,4-dienoyl-CoA reductase 1 | 0.426 | 0.885 | 4.5E-14 |
|
disease | 0.500 | limited | 1.000 | 2 | 0 | 2014 | 2015 | ||||||||
|
adenine phosphoribosyltransferase | 0.423 | 0.846 | 5.5E-13 |
|
disease | 0.800 | None | 1.000 | 1 | 0 | 1985 | 2012 | ||||||||
|
dehydrogenase E1 and transketolase domain containing 1 | 0.711 | 0.385 | 2.8E-30 |
|
disease | 0.700 | None | 1.000 | 2 | 6 | 2012 | 2016 | ||||||||
|
hydroxysteroid 17-beta dehydrogenase 10 | 0.656 | 0.538 | 0.94 |
|
phenotype | 0.750 | definitive | 1.000 | 17 | 10 | 1999 | 2019 | ||||||||
|
acyl-CoA dehydrogenase short/branched chain | 0.691 | 0.500 | 2.7E-11 |
|
disease | 0.700 | definitive | 1.000 | 8 | 4 | 2000 | 2016 | ||||||||
|
endoglin | 0.446 | 0.846 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
growth differentiation factor 2 | 0.529 | 0.731 | 2.5E-03 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
aquaporin 1 (Colton blood group) | 0.467 | 0.885 | 2.6E-07 |
|
phenotype | 0.300 | moderate | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
potassium two pore domain channel subfamily K member 3 | 0.584 | 0.654 | 0.90 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
SMAD family member 1 | 0.533 | 0.731 | 0.99 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 |